Table 5. Summary table of the cross-platform analyses of LEDGF/p75 transcript and protein expression in various human tumor types as compared to corresponding normal tissues.
Cancer type | Oncomine | Q-PCR | Immunohistochemistry |
Bladder | X | No data | X |
Breast | ↑ | ↑ | X |
Cervix | ↑ | No data | X |
Colon | ↑ | ↑ | ↑ |
Esophagus | ↑ | No data | X |
Gall bladder | No data | No data | X |
Kidney | ↑ | X | X |
Head and neck | ↑ | No data | X |
Liver | ↑ | X | ↑ |
Lung | ↑ | X | X |
Lymphoma | ↑ | No data | X |
Ovary | ↑ | X | X |
Pancreas | ↑ | No data | X |
Prostate | ↑ | ↑ | ↑ |
Rectum and anus | ↑ | No data | X |
Salivary gland | ↑ | No data | X |
Skin | ↑ | No data | X |
Small Intestine | No data | No data | X |
Stomach | ↑ | No data | X |
Thyroid | No data | ↑ | ↑ |
Uterus | X | No data | ↑ |
↑, Statistically significant (p<0.05) increase in LEDGF/p75 expression in tumors versus normal tissues;
X, No statistically significant (p<0.05) change in LEDGF/p75 expression in tumors versus normal tissues; No data, no datasets or tissues available.